Summary
In a significant market movement during April 2022, Epitopea was the subject of a vc funding. The transaction achieved a gross valuation of £10,300,000. Leading the round was Novateur Ventures, Advent Life Sciences, Cambridge Innovation Capital, Fonds de solidarité FTQ, Harrington Discovery Institute, CTI Life Sciences.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Novateur Ventures
Lead Investor / Acquirer
Advent Life Sciences
Lead Investor / Acquirer
Cambridge Innovation Capital
Lead Investor / Acquirer
Fonds de solidarité FTQ
Lead Investor / Acquirer
Harrington Discovery Institute
Lead Investor / Acquirer
CTI Life Sciences
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in